Analysis of patient access to orphan drugs in Turkey

BACKGROUND: Rare diseases are life-threatening, serious, and chronic conditions that require complex care and have a low prevalence. An estimated one in 15 people worldwide are affected by rare diseases. This study aims to analyze the accessibility, reimbursement status, licensed status, and Anatomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Koçkaya, Güvenç, Atalay, Sibel, Oğuzhan, Gülpembe, Kurnaz, Mustafa, Ökçün, Selin, Sar Gedik, Çiğdem, Şaylan, Mete, Şencan, Nazlı
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868010/
https://www.ncbi.nlm.nih.gov/pubmed/33549137
http://dx.doi.org/10.1186/s13023-021-01718-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868010/
https://www.ncbi.nlm.nih.gov/pubmed/33549137
http://dx.doi.org/10.1186/s13023-021-01718-3

Ejemplares similares